NasdaqGS - Nasdaq Real Time Price USD
Vor Biopharma Inc. (VOR)
Tune into live earnings calls Now streaming directly on quote pages.
0.1600
-0.0125
(-7.25%)
At close: May 13 at 4:00:01 PM EDT
0.1700
+0.01
+(6.25%)
After hours: May 13 at 7:57:25 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 56,166,260 | 6 |
| Sales | 15,115 | 3 |
| Net Shares Purchased (Sold) | 56,151,145 | 9 |
| Total Insider Shares Held | 39.85M | -- |
| % Net Shares Purchased (Sold) | -344.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ATTAR EYAL C Officer | Sale at price 1.42 per share. | Direct | 3,162 | Feb 13, 2025 |
| ATTAR EYAL C Officer | Sale at price 1.37 per share. | Direct | 3,499 | Feb 10, 2025 |
| ANG ROBERT M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| ATTAR EYAL C Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| CHAKRABORTY TIRTHA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| CHOI HAN WOOK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| RA CAPITAL MANAGEMENT, L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Dec 30, 2024 |
| REPROGRAMMED INTERCHANGE LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.19 per share. | Indirect | 46,379,180 | Dec 30, 2024 |
| ATTAR EYAL C Officer | Sale at price 1.25 per share. | Direct | 12,918 | Dec 27, 2024 |
| ATTAR EYAL C Officer | Sale at price 1.39 per share. | Direct | 20,357 | Jun 3, 2024 |
| ANG ROBERT M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
| ATTAR EYAL C Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
| CHAKRABORTY TIRTHA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
| JORGENSEN NATHAN D. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
Related Tickers
KROS Keros Therapeutics, Inc.
13.47
-1.97%
CTMX CytomX Therapeutics, Inc.
2.5000
+17.37%
XLO Xilio Therapeutics, Inc.
1.1500
+57.32%
NCNA NuCana plc
0.0329
-17.75%
CRVS Corvus Pharmaceuticals, Inc.
3.8900
-4.07%
TOVX Theriva Biologics, Inc.
0.5600
+8.21%
PLRZ Polyrizon Ltd.
0.0285
-91.86%
LYRA Lyra Therapeutics, Inc.
0.0944
+0.21%
GBIO Generation Bio Co.
0.3927
+0.59%
CYTK Cytokinetics, Incorporated
30.61
-4.73%